Statistics
Publications
27
Citations
1.5K
H-Index
22
Active since
2006
Marek Pruszyński is an author at Instytut Chemii i Techniki Jądrowej specializing in radionuclide therapy, oncology, and nanomedicine.
Publications per year
2006–2022
27
27
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
Matthias D’Huyvetter, Jens De Vos, Catarina Xavier et al. · Clinical Cancer Research · 2017 · 180 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
Marek Pruszyński, Eftychia Koumarianou, Ganesan Vaidyanathan et al. · Nuclear Medicine and Biology · 2012 · 107 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 27